Literature DB >> 28332936

Ethical Concerns About Emerging Treatment Paradigms for Gender Dysphoria.

Stephen B Levine1.   

Abstract

The increasing incidence of requests for medical services to support gender transition for children, adolescents, and adults has consequences for society, governmental institutions, schools, families, health-care professionals, and, of course, patients. The sociological momentum to recognize and accommodate to trans phenomena has posed ethical dilemmas for endocrinologists, mental health professionals, and sexual specialists as they experience within themselves the clash between respect for patient autonomy, beneficence, nonmaleficence, and informed consent. The larger ethical clashes are cultural and therefore political. There is a distinct difference between pronouncements that represent human rights ideals and the reality of clinical observations. Some interpret this clash as a moral issue. This article delves into these tensions and reminds apologists from both passionate camps that clinical science has a rich tradition of resolving controversy through careful follow-up, which is not yet well developed in this arena.

Entities:  

Mesh:

Year:  2017        PMID: 28332936     DOI: 10.1080/0092623X.2017.1309482

Source DB:  PubMed          Journal:  J Sex Marital Ther        ISSN: 0092-623X


  3 in total

1.  Using circular questions to explore individual family member experiences of youth gender dysphoria in Australia.

Authors:  Jason J Westwater; Elizabeth Riley; Gregory M Peterson
Journal:  Int J Transgend Health       Date:  2020-06-12

2.  The Gender Affirmative Treatment Model for Youth with Gender Dysphoria: A Medical Advance or Dangerous Medicine?

Authors:  Alison Clayton
Journal:  Arch Sex Behav       Date:  2021-11-22

Review 3.  Gender Dysphoria: Bioethical Aspects of Medical Treatment.

Authors:  Marta R Bizic; Milos Jeftovic; Slavica Pusica; Borko Stojanovic; Dragana Duisin; Svetlana Vujovic; Vojin Rakic; Miroslav L Djordjevic
Journal:  Biomed Res Int       Date:  2018-06-13       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.